The Importance of Cryoglyphylobelemia

I've stopped collecting patients just because I have so many good options in clinical trials and even for patients at the very end, I still use fluderebi or clangerine. Those are highly active agents. It's just that there's more toxic and they're so immunosuppressive. They're just not good choices up front, but they still work. But if you go look at what is recently published article out of the EU, led by British investigators and transplant, it was used and was quite effective.